An update on equine postoperative ileus: Definitions, pathophysiology and management. by Lisowski, Zofia et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An update on equine postoperative ileus: Definitions,
pathophysiology and management.
Citation for published version:
Lisowski, Z, Pirie, R, Blikslager, A, Lefebvre, D, Hume, D & Hudson, N 2018, 'An update on equine
postoperative ileus: Definitions, pathophysiology and management.' Equine Veterinary Journal, vol. 50, no.
3, pp. 292-303. DOI: 10.1111/evj.12801
Digital Object Identifier (DOI):
10.1111/evj.12801
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Equine Veterinary Journal
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
A
cc
ep
te
d 
A
rt
ic
le
This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1111/evj.12801 
This article is protected by copyright. All rights reserved. 
MISS ZOFIA MARIA LISOWSKI (Orcid ID : 0000-0002-1323-9593) 
 
Article type      : Review Article 
 
An update on equine postoperative ileus: Definitions, 
pathophysiology and management 
 
Z. M. Lisowski1, R. S. Pirie1, A. T. Blikslager2, D. Lefebvre1, D. A. Hume1,3 and N. P. H 
Hudson1 
 
1The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 
9RG, UK 
2Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27502, USA 
3
Mater Research, The University of Queensland, 27 Kent St, Woolloongabba, Queensland 4104, Australia. 
*Corresponding author email: zofia.lisowski@roslin.ed.ac.uk 
 
Keywords: horse; colic; surgery; POI; abdomen; gastrointestinal motility 
 
Summary 
Postoperative ileus (POI) is a serious condition which any horse undergoing abdominal surgery is at 
risk of developing, leading to increased hospitalisation time and resulting costs. Advances in the 
understanding of the development of equine POI are mainly based on human and rodent literature, 
where manipulation-induced inflammation has been identified as a key trigger, with activation of 
resident muscularis externa macrophages playing a crucial role in the pathophysiology. Despite 
many pharmacological trials in all species, there is no single completely successful treatment for POI, 
highlighting that the condition is multifactorial in cause and requires a multimodal approach to 
minimise its incidence. 
Introduction 
The term postoperative ileus (POI) describes the cessation of, or reduction in, gastrointestinal transit 
(GIT) following surgical stress [1]. Efforts have been made in human medicine to establish a 
standardised definition of POI [2; 3], an exercise which, based on the variation in POI definitions 
used amongst equine clinicians [4-10], also appears warranted in the field of equine veterinary 
medicine. In the horse, POI is almost exclusively associated with gastrointestinal (GI) surgery. In 
human medicine, it has also been reported following non-GI surgeries, including orthopaedic and 
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gynaecological procedures. POI has the potential to significantly increase hospitalisation time, 
treatment costs and postoperative morbidity and mortality and is, therefore, of significant concern 
to both the medical and veterinary professions. The estimated financial impact of human POI in 
North America alone approximates US $1.46 billion/year as a result of increased hospitalisation and 
treatment costs [11]. Horses that develop POI are much less likely to survive after surgery [12; 13]. In 
recent years, equine POI research has largely focused either on (a) the provision of descriptive 
statistics relating to the syndrome (e.g. incidence and survival rates), (b) the identification of 
associated risk factors, and (c) determining the efficacy of certain therapeutic and prophylactic 
interventions. There are little research-derived data focused on the pathogenesis of the syndrome in 
the horse, with reliance placed on the translational application of data derived from other species. 
Therefore, this review highlights some of the proposed key mechanisms in the pathophysiology of 
POI, derived from other species, and considers whether the translational application of these 
mechanisms to the horse can inform our interpretation of equine-derived data pertaining to risk 
factors and therapeutics.  
Definitions and clinical features 
General and human 
The word ileus derives from the Greek word εἰλεός or eileós (meaning “twisting” or “rolling”) and 
was initially defined in human medicine as “severe and prolonged twisting of the intestine”, 
whereby the term could be applied to several conditions (e.g. intussusception, volvulus) which 
shared several presenting symptoms. This particular use of the term ceased in the 19th century 
following the adoption of a classification system of intestinal obstruction based on specific cause 
[14] and more recently its use was further restricted to a state of reduced or absent peristalsis as a 
result of a non-mechanical pathological response of the GI tract [1; 15]. Consequently, the majority 
of references to the term POI in current literature define the syndrome as a delay in the return of 
normal GI motility following surgery, or ‘a syndrome of functional inhibition of propulsive bowel 
motility’ [15].  
In humans, overall intestinal motility should be normal by 5 days postoperatively. The small intestine 
(SI) recovers within 5 -10 hours, followed by return of gastric function at 24 – 48 hours, with a more 
prolonged time for restoration of colonic function (3-5 days) [16; 17]. Defaecation and tolerance of 
solid food ingestion are considered to reflect recovery of GIT following surgery in humans and are 
regarded as appropriate primary outcome measures in clinical trials of POI and decision-informing 
criteria relating to readiness for discharge [18]. 
In humans, various additional qualifying terms have been applied to POI, such as ‘physiological (or 
normal) POI’, ‘pathological (or prolonged) POI’ (PPOI) and ‘recurrent PPOI’ (RPPOI). The criteria used 
for classification vary greatly, which probably contributes to the disparity in certain study-derived 
data. For example, the reported incidence of human POI ranges from 2% to 60% depending on the 
POI or PPOI descriptors applied in the study [2; 19]. Efforts to establish more specific criteria for each 
of these POI subcategories [2] might facilitate comparisons between individual studies.   
Equine 
Similar differences in diagnostic criteria probably underlie marked variation (0 – 62%) in the reported 
equine POI prevalence rates following abdominal surgery (Supplementary Item 1).  The presence of 
nasogastric reflux on intubation represents a universally applied diagnostic criteria which, along with 
ultrasonographic and palpable (via per rectum examination) evidence of distended SI are the most 
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commonly applied diagnostic indications [8; 9].  The ambiguity in POI definition is largely attributable 
to variations in the volume or rate of reflux as well as the inclusion or omission of associated clinical 
signs such as tachycardia and abdominal discomfort. There is a wide disparity in the volume of reflux 
considered to reflect the presence of POI, either on a single intubation and/or over multiple 
intubations within a 24-hour period (Supplementary Item 1). In an effort to standardise the 
definition of POI across all studies, Merritt and Blikslager (2008) proposed the following clinical 
criteria: gastric reflux of ≥4 l upon any given intubation, or >2 l/h on repeated intubation, of gastric 
contents of pH >4.0; persistent tachycardia (>40 beats/min); mild to severe signs of abdominal 
discomfort; rectal and/or ultrasonographic evidence of multiple loops of fluid distended small bowel 
[6]. Recent surveys of European and American equine clinical specialists confirmed the presence of 
nasogastric reflux as the most important criterion for defining POI but there was no consensus with 
respect to the rate and volume of reflux adopted as diagnostic markers [8; 9].   Agreement on, and 
adherence, to a universal syndrome definition would be a significant advance in POI research. 
The term postoperative reflux (POR), proposed to describe solely the presence of reflux following 
surgery without any causal assumptions [20] includes both mechanical obstructions and functional 
motility inhibition as potential underlying mechanisms. In the interest of clarity, this review will 
focus on POI; namely, the functional inhibition of motility following abdominal surgery.  
As in humans, a transient decrease in intestinal motility probably occurs normally following equine 
abdominal surgery. Data are available on the influence of anaesthesia (with or without orthopaedic 
surgery) on GIT. Orally administered chromium oxide was detected in faeces for 18-90 hours 
following general anaesthesia alone [21] and 15-105 hours following general anaesthesia (isoflurane) 
and orthopaedic surgery [22].  Following experimental jejunocaecostomy, Sasaki et al. (2008) 
demonstrated an immediate reduction in caecal motility which lasted 2 days; this was followed by 
an unstable period lasting 7 days and then a period of gradual recovery lasting up to 31 days [23]. 
However, unlike humans, where large intestinal (LI) dysmotility is commonly recognised and 
reflected in a delay in defaecation [17; 18], the clinical significance of POI in the horse is 
predominantly related to the SI. Therefore, data on the time taken for normal restoration of SI 
motility in a cohort of horses following abdominal surgery would have greater clinical relevance. 
The greater clinical significance of SI dysmotility in equine POI may mask LI involvement. Nelson et 
al. (2013) demonstrated a greater delay in postoperative passage of first faeces in horses which had 
postoperative GI complications, compared with those that did not, following elective non-GI surgery 
[24]. Little et al. (2001) independently demonstrated only a 12% prevalence of postoperative colic in 
horses with reduced faecal output following non-GI surgery [25].   Faecal output measurement might 
enable the early identification of cases with ‘LI POI’, thus enabling the implementation of treatment 
before the development of caecal or large colon impactions.  
Diagnosis of Equine POI - Mechanical versus functional 
As discussed above, equine POI is most frequently diagnosed by the presence of reflux following 
nasogastric intubation. The ultrasonographic and/or palpable (via per rectum examination) detection 
of distended SI, tachycardia, abdominal discomfort, reduced faecal output and reduced/absent 
borborygmi are also valuable means of POI diagnosis [8; 9]. Importantly, the above clinical signs may 
also be present in other conditions, particularly those associated with a mechanical obstruction to 
the aboral passage of SI ingesta and fluid. In the immediate postoperative period, most 
consideration is given to an obstruction at the anastomosis site [10]. Clinical distinction between a 
functional and physical obstruction is challenging. Although mechanical obstructions associated with 
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leakage at the anastomosis site would likely result in worsening pain, increasing rectal temperature 
and cardiovascular deterioration, those attributable to adhesions or simple intestinal kinking may, 
like POI, simply result in distended SI and persistent gastric reflux.  The absolute distinction between 
these differing disorders may require a second laparotomy, re-examination of the anastomosis site 
and confirmation that no physical obstruction is present.  In one study of 27 horses that underwent 
relaparotomy (out of 254 that survived the 1st surgery) the most common diagnoses were functional 
ileus (25.9%) and obstruction at the site of anastomosis (22.2%). However, of those that underwent 
a second laparotomy 62% developed POI [26]. In a more recent study of 22 horses that underwent 
relaparotomy, 16 out of 19 horses with precipitating clinical signs (POR and postoperative colic) had 
these clinical signs eliminated by relaparotomy; furthermore, the authors reported that 
relaparotomy did not appear to exacerbate the POR [27]. 
 
Epidemiology and risk factors for equine POI 
Equine surgical cases with SI lesions are consistently associated with an increased risk of POI. 
Extensive manipulation of the intestines associated with decompression and performing resections 
and anastomoses of the intestine is likely to induce a greater degree of tissue damage and a more 
profound inflammatory response in the muscularis [28]. Additionally, studies in mice have 
demonstrated that even exteriorisation of SI from the abdominal cavity is also likely to contribute to 
the inflammatory response [29]. While some equine studies have reported a greater risk of POI in 
cases with strangulating, compared with non-strangulating, SI lesions [30; 31], others have failed to 
identify such an association [5; 7; 13].  The onset of pathology is probably attributable to endotoxin 
release from ischaemic bowel resulting in systemic endotoxaemia [32], which, in itself, will result in 
reduced intestinal motility [33]. One study identified the presence of a strangulating pedunculated 
lipoma as a specific risk factor for POI, a finding which may reflect a dual association with both 
intestinal ischaemia and age, the latter also being reported as a significant risk factor for POI [34]. 
Other common risk factors relate to cardiovascular and haematological status. High packed cell 
volume (PCV) at the time of admission [5; 7; 31; 34; 35], increased serum total protein concentration 
[7; 35] and tachycardia [5] have all been associated with an increased risk of horses developing POI. 
These parameters all reflect a degree of dehydration and/or hypovolaemia resulting from both 
haemodynamic consequences of endotoxaemia and fluid sequestration within obstructed bowel 
and, therefore, may simply reflect the strangulating nature of the underlying intestinal lesion.   
Performing a pelvic flexure enterotomy may reduce POI risk [7; 13]; although this may be restricted 
to cases with LI, but not SI lesions [35]. Although the protective influence of this procedure may be 
attributable to a reduction in the intraluminal source of endotoxin, the potential value of evacuating 
the colon should be weighed against the increased anaesthesia and surgical time required to 
perform the surgery, as both factors have been associated with an increased risk of POI [7; 25]. 
Pathophysiology of POI  
The development of POI has been attributed to several causes and mechanisms. These include the 
following: anaesthetic agents, opioids, intravenous fluids, electrolyte imbalances, disruption to GI 
hormones and neuropeptides, disruption of neural continuity, autonomic dysfunction and 
inflammatory cell activation [36]. Such contributory factors may act in isolation or in combination, 
ultimately resulting in a common endpoint; namely, impaired contractility of the intestinal smooth 
muscle (SM).   
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The majority of POI research has been performed on rodent models with only a relatively small 
number of studies in the horse. The most commonly used rodent POI model relies on small intestinal 
manipulation (IM) to induce ileus [29; 37], thus replicating, in part, the processes normally involved 
in abdominal and GI surgery. This model does not account for the additional processes of intestinal 
resection, enterotomies and large intestinal manipulation which are regularly undertaken and 
associated with an increased risk of equine POI. It is currently accepted that the pathogenesis of POI 
involves two phases: an initial neurogenic phase resulting in immediate postoperative impairment of 
bowel motility and a subsequent inflammatory phase lasting for several days. Despite representing 
distinct phases in POI progression, recent findings support a bi-directional interaction between the 
nervous and immune system. 
Neurogenic phase 
During abdominal surgery, the surgical incision, peritoneal breach and IM act as nociceptive stimuli 
that activate neural pathways (Fig 1). Surgical incision of the abdominal wall of rats creates a somatic 
wound activating adrenergic pathways [38; 39]. This pathway involves a spinal reflex; afferent 
splanchnic nerves synapse in the dorsal column of the spinal cord, stimulating glutamate release. 
Both activate spinothalamic projections causing the perception of pain at the surgical incision and 
mediate a sympathetic efferent response, resulting in reduced motility [15; 39-42]. The degree of 
ileus relates to the length of incision [41] and depletion of adrenergic innervation prevents this [42-
44]. 
IM and breach of the peritoneum is a more intense stimulus than the skin incision alone, and in turn 
results in a longer period of inhibition of motility [38; 39], which, in rats, is only partially blocked by 
adrenergic antagonists [45]. As early as 1899, Starling and Bayliss observed a reduction in intestinal 
motility following intestinal handling in the dog, a phenomenon which was abolished by sectioning 
the vagus and splanchnic nerves [46]. As largely deduced from rodent studies, sensory information 
from the peritoneum and intestine is conveyed via the vagus nerve which, through the expression of 
interleukin-1 receptors (IL-1R) [47], is also sensitised by inflammatory stimuli. Afferents travel to the 
nucleus tractus solitarius of the brainstem, resulting in corticotrophin-releasing factor-mediated 
stimulation of neurons in the supraoptic nucleus of the hypothalamus. Hypothalamic neurons then 
project to sympathetic preganglionic neurons in the spinal cord, activation of which inhibits GI 
motility [40; 48-50]. Intense stimulation of splanchnic afferents, also triggers an inhibitory non-
adrenergic, non-cholinergic vagally-mediated pathway that impairs motility via local release of nitric 
oxide (NO) and vasoactive intestinal peptide [38; 51]. Neuronal inhibition of GI motility is self-
limiting, with normalisation of function returning upon cessation of nociceptor and 
mechanoreceptor stimulation. In comparison, the subsequent inflammatory response, and its effect 
on motility, results in a significantly more prolonged period of ileus. These two periods, an early 
neurogenic phase, and a later inflammatory phase have been recognised in humans [52] and 
hypothesised in horses [53]. 
Inflammatory phase 
Results derived predominantly from rodent studies have attributed the prolonged phase of POI to 
inflammation within the intestinal muscularis [37; 54; 55].  Accordingly, the experimental induction 
of POI by IM has been prevented by the inhibition of mast cells [56], macrophages [57] or more 
general leukocytic infiltration [58; 59]. 
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The activation of peritoneal mast cells, located within the serosa and mesentery and in close 
association with afferent nerve fibres [60], is an early event during abdominal surgery reported in 
the mouse [56] and human [61]. Neuropeptides (substance P or calcitonin gene-related peptide) 
released from afferent nerves have been hypothesised as playing a role [62; 63]. In addition to the 
release of histamine, mast cell proteinase-1, tryptase and IL-6 [61], activated mast cells also release 
IL-8 which, along with intercellular adhesion molecule-1 (ICAM-1), may directly result in neutrophil 
chemotaxis [64].  Alternatively, their close association with mesenteric blood vessels may facilitate 
the diffusion of mediators directly into the mesenteric circulation, resulting in the recognised 
increase in epithelial permeability following intestinal manipulation. This may in turn permit either 
the translocation of luminal-derived pathogen-associated molecular patterns (PAMPs) across the 
intestinal mucosa and/or stimulate the production of damage-associated molecular patterns 
(DAMPs), both of which may trigger a subsequent key step in the inflammatory cascade;  namely, 
the activation of resident muscularis macrophages (MM) [37]. Notwithstanding these findings, 
intestinal inflammation and delayed GIT following IM were still present in a mast cell-deficient 
mouse strain [65].  
Activation of MM occurs through DAMPs, such as adenosine triphosphate (ATP) [66], and PAMPs, 
such as lipopolysaccharide (LPS) [67]. In mice, the activation of toll-like receptors (TLR) and receptors 
for advanced glycation end products (RAGE) by PAMPs and DAMPs, results in recruitment of 
intracellular signalling pathways (p38, JNK/SAP), the activation of which are increased within an hour 
of IM [68]. This subsequently leads to the release of pro-inflammatory cytokines, including tumour 
necrosis factor-α (TNF-α), IL-1β and IL-6, and chemokines, including macrophage inflammatory 
protein -1α (MIP-1α) and monocyte chemoattractant protein-1 (MCP-1), with a resultant 
upregulation of ICAM-1 in the endothelium and the influx of leukocytes [28; 37; 69]. The leukocytic 
infiltrate, which predominantly comprises monocytes, mast cells and neutrophils, is detectable 
within 3 hours following surgery and continues to increase until it peaks at approximately 24 hours 
[54; 55]. Inducible NO synthase (iNOS) and cycloogygenase-2 (COX-2) [70] upregulation has been 
reported in MM in rodents, thus facilitating the production of NO and prostaglandins, both of which 
impair the contractile activity of SM cells [70]. Prostaglandins also increase the sensitivity of spinal 
afferent nerves [47]. Macrophage depletion (with chlodronate liposomes and using a mutant mouse 
with an inactivated colony stimulating factor-1 gene resulting in absence of muscularis 
macrophages) prevents intestinal inflammation and the development of POI [57], strongly 
supporting their role in the inflammatory phase of POI. 
As mentioned previously, most of the studies of POI are performed on the SI. A recent study by Pohl 
et al. has shown differences in the inflammatory response of resident cells in the SI and colon in a 
mouse model of POI [71]. Whilst activation of resident MM in the SI is a result of translocation of 
luminal derived DAMPs or PAMPs, this does not occur with the colonic MM, a result of the colonic 
MM macrophages being less reactive, most likely reflecting the larger microbial load in the colon. In 
addition, differences in the response of infiltrating monocytes, and evidence that monocytes in the 
colon are affected by the microbiota, highlights significant regional differences in the response of 
the SI and colon to IM [71]. 
As in every tissue injury, immune cells and their products also contribute to the resolution of 
inflammation and POI; one key effector is IL-10.  IL-10 knockout mice fail to resolve their muscularis 
inflammatory response compared to wild type mice, resulting in high mortality rates [72]. 
Administration of exogenous IL-10 improved GIT postoperatively and reduced inflammatory 
cytokines, chemokines and NO.  Additionally, whilst the initial leukocytic infiltrate of neutrophils and 
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monocytes to the muscularis has been associated with SM dysfunction leading to POI, the role of 
monocytes/macrophages in resolution of POI has not been studied, until recently. Farro et al. (2017) 
demonstrated that blocking the influx of monocytes to the muscularis did not prevent POI but 
resulted in a prolonged period of smooth muscle dysfunction and an increased neutrophilic 
inflammatory response [55]. The administration of macrophage colony stimulating factor-1 fusion 
protein (CSF1-Fc) [73] not only restored monocyte and MM numbers but reduced neutrophil 
infiltration in the muscularis, increased anti-inflammatory gene expression and improved GIT transit 
time following IM [55]. Continued work focusing on the recovery process is warranted, with the 
potential to inform the development of therapeutic interventions which accelerate this process 
rather than solely targeting the onset of inflammation.  
In the horse, postoperative neutrophilic and eosinophilic inflammation of the jejunum has been 
identified up to 18 hours postoperatively [28; 74; 75]. Direct manipulation of the LI in the horse 
resulted in an inflammatory response; this also occurred following manipulation of the SI alone [75]. 
A similar response has been reported in rodents [76]. In addition to this pan enteric response, an 
increase in apoptotic cells (neurons, SM and glial cells) has been demonstrated in strangulating 
lesions of the LI and SI at sites distant to the lesion, most likely reflective of a generalised stress 
response of the GI tract to ischaemia, reperfusion and inflammation [77]. A localised stress response 
in the SM and neurons has been reported in the borders of healthy resection margins [78]. 
Activation of MM by manipulation-induced translocation of luminal-derived LPS is a recognised 
phenomenon in humans and rodents leading to loss of SM contractility [67; 79]. In light of IM-
induced loss of mucosal epithelial cells in the horse it is likely that a similar LPS translocation process 
also occurs in this species [75]. IM-induced inflammation in a TLR-2 and TLR-4 double knockout 
mouse model, was only partially protected against a delay in GIT [80], demonstrating that alternative 
TLR-2 and TLR-4 independent pathways must also exist. 
Although the translational application of data derived from rodent models can provide a valuable 
insight into the basic cellular and molecular responses of the equine GI tract to celiotomy and IM 
there are significant differences in innate immune biology.  For example, handling-induced NO 
liberation by murine MM contributes towards intestinal SM dysfunction in the mouse GI tract [81], 
but like other large animals (pigs and humans [82]) equine alveolar and peritoneal macrophages do 
not produce NO, so this mediator is not likely to be involved in equine inflammation [83].  
Another important factor to consider when extrapolating findings from rodent studies to equine 
colic cases is the absence of pre-existing conditions, such as ischaemic bowel, peritonitis and 
endotoxaemia in rodent models of IM used to study POI. A model of caecal ligation and perforation 
in rats resulted in reduced GI motility and a leukocytic inflammatory response within the muscularis 
[84]. Whilst not a model of POI that is used in the majority of rodent studies, it does demonstrate 
the effect of polymicrobial sepsis on GI motility. Horses undergoing abdominal surgery will usually 
have significant primary disease, such as ischaemic bowel, peritonitis associated with non-viable 
intestine and intestinal distention secondary to a strangulation/amotility. As mentioned earlier, 
endotoxin release from ischaemic bowel can cause reduced intestinal motility [32; 33]. Horses with 
amotile intestine may also have increased bowel oedema because of reduced lymphatic drainage 
[85; 86]. How these pre-surgical factors affect the pathogenesis of equine POI is not known, but 
given horses presenting with compromised cardiovascular status/endotoxaemia [5; 7] and with pre-
operative reflux [13] are at increased risk of developing POI (see section above) one could assume 
that they play a significant role in the pathogenesis of equine POI.  
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Pharmacological/therapeutic influences 
In addition to the key neurogenic and inflammatory phases of POI, a variety of pharmacologic agents 
and therapeutic interventions have also been identified as either increasing the risk or duration of 
POI. 
Opioids 
The negative effects of opioids on GI motility have been well documented in the literature for both 
horses [87-89] and man [90], with opiate administration in man being recognised as a contributing 
factor to POI development [91; 92]. Two large scale questionnaire surveys of American and 
European equine clinical specialists revealed a widely-held view that opioid use was ‘not a very 
important’ risk factor for the development of POI [8; 9]. However, despite this dominant opinion, 
87% of those reporting a POI incidence greater than the median incidence, declared the use of 
opioids in their treatment regimens. Opioids mediate their effect on opioid receptors, of which there 
are three types: delta (δ) kappa (κ) and mu (μ). These receptors are found throughout the central 
(CNS) and peripheral nervous systems, with μ and κ receptors present in the excitatory neurons 
innervating the intestine. Stimulation of CNS opioid receptors induces analgesia, but stimulation of 
μ- and κ-receptors in the GI tract influences several physiological functions including motility. Opioid 
receptor agonists inhibit acetylcholine (Ach) release, resulting in an increase in SM tone and reduced 
intestinal motility [93]; in contrast, opioid antagonists may reduce this effect. This is evidenced by 
the accelerated postoperative recovery of GI motility following the oral administration in humans of 
the peripherally-acting μ-opioid antagonist, alvimopan [94]. In the horse, administration of the µ-
opioid receptor antagonist naloxone resulted in an increase in LI motility, potentially reflecting a role 
for endogenous opioids in modifying intestinal activity [95-97]. Predictably, μ-agonists without 
anticholinergic activity have the least detrimental effect on jejunal motility [98], potentially 
rendering them more suitable analgesics for postoperative use although a study assessing the 
benefit of butorphanol, a partial agonist and antagonist of the μ-opioid receptor and partial agonist 
of the κ-receptor, following celiotomy produced a transient decrease in faecal production 24 hours 
postoperatively [99]. Despite this decrease being short-lived, the prolongation of time to first 
passage of faeces may impair the ability of the clinician to accurately assess the postoperative case. 
The overall evidence for their inhibitory effects on intestinal motility generally precludes their 
routine perioperative use in horses undergoing abdominal surgery. 
Anaesthetic agents 
All anaesthetic agents affect GI motility by affecting the myoelectric activity of the intestine [100]. 
Drugs used for anaesthetic maintenance such as halothane and isoflurane reduce GI motility in 
horses undergoing non-GI abdominal procedures with halothane having a more profound affect than 
isoflurane [22]. Although duration of anaesthesia has been identified as an increased risk factor for 
POI in the horse (Supplementary Item 1), it is unclear whether this association is attributable to 
increased exposure to anaesthetic agents, increased bowel handling in more protracted surgeries or 
a combination of both.  
Intravenous fluid therapy and electrolyte imbalances 
Electrolyte disturbances, particularly hypocalcaemia and hypomagnesaemia, are commonly 
associated with equine GI disease and horses with low postoperative serum magnesium and calcium 
levels are at increased risk of developing POI [101; 102]. Similarly, in man, POI is associated with 
electrolyte disturbances such as hypokalaemia and hyponatraemia [91; 103]. From both a 
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prophylactic and therapeutic viewpoint, it is important to monitor at-risk patients for underlying 
electrolyte derangements and apply the appropriate corrective approach. This often necessitates the 
intravenous administration of polyionic crystalloid fluid. However, despite the associated benefits of 
restoring and maintaining an appropriate electrolyte status, certain detrimental effects of 
overzealous crystalloid fluid administration have also been reported. In humans, crystalloid overload 
is associated with an increased duration of ileus and bowel recovery times [104; 105] and a higher 
risk of leakage at the anastomoses site has been demonstrated in rodent models [106]. Oedema of 
the intestine as a result of fluid overload results in delayed intestinal transit and altered gut barrier 
functions due to decreased mesenteric blood flow, increased stretch of the intestine and altered 
sodium channel exchange expression [107]. These three factors consequently cause signal 
transducer and activator of transcription 3 (STAT-3) and nuclear factor-κβ (NFκβ) activation and 
reduction of myosin light chain phosphorylation of the intestinal SM, such that the contractile 
activity of the muscle is reduced [86; 108]. Oedema subsequent to reduced or absent peristalsis 
could arise from a reduction in lymphatic drainage and a subsequent accumulation of interstitial 
fluid [85; 86]. Colloid administration has not been shown to increase the risk of POI in humans in a 
retrospective study, potentially due to avoidance of third space fluid loss or a reduction in any third 
space fluid loss associated with crystalloid administration [109]. IVFT fluid regimes in humans 
undergoing abdominal surgery are varied but broadly come under 3 categories; liberal, zero balance 
and restrictive fluid regimes. Liberal is defined as greater than 2.75 L/day (1.9 ml/kg/h for a 60 kg 
human); zero balance between 1.75-2.75 L/day and restrictive as less than 1.75 L/day in the 
postoperative period [110]. Several studies have shown the potential benefit of restrictive regimes in 
postoperative recovery [104; 105; 110], with oral fluids being introduced as soon as possible 
following surgery [111]. As a result, there is currently a large clinical study being performed in 
humans to fully evaluate fluid regimes and postoperative recovery, with results due in 2018 [112]. 
Fluid rates usually used in the horse are maintenance at 2.5 ml/kg/h with an anaesthesia 
maintenance rate of 10 ml/kg/h [113] meaning equine fluid rates used are similar to liberal regimes 
in humans. Whilst no study has specifically addressed different fluid regimes in the horse and their 
effect on postoperative recovery, one study in the horse has identified duration of fluid therapy with 
an increased risk of POI [114]. 
Surgical factors 
Good surgical technique is important to ensure a successful surgical outcome postoperatively. Any 
surgical procedure involving resection of the intestine will affect the migrating myoelectrical 
complex resulting in a disruption to the contractile activity of the SM [115].   
Leakage at the anastomosis site for any reason is associated with prolonged recovery times in 
humans. This can manifest as the development of either acute, severe symptoms in the early post-
operative period or delayed, more subtle symptoms [116].  In general, anastomotic leaks in humans 
are diagnosed 5-8 days post-operatively, although more delayed recognition (up to 12 days) has 
been reported [117]. Rarely do equine POI cases present clinically following such a protracted post-
operative period [118], a finding which questions the relative importance of anastomotic leaks, 
compared with functional inhibition of intestinal motility, in equine POI. In addition, most human 
studies refer to colorectal surgery; consequently, data on human anastomotic leaks may not directly 
correlate with leakage at the site of SI anastomoses in horses. The identification of anastomotic 
leaks in humans is facilitated by the use of abdominal radiography and contrast CT, both techniques 
which are not applicable to the horse. Although clinical signs (e.g. pyrexia, inappetence, tachycardia), 
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worsening endotoxaemia, clinical pathology results (e.g. haematology, peritoneal fluid analysis) and 
ultrasonographic findings (e.g. increased peritoneal fluid volume, fibrin deposition) may raise 
diagnostic suspicion of anastomotic leaks in the horse, ultimate diagnostic confirmation can only be 
achieved by a repeat laparotomy. Considering the relative rarity of a repeat laparotomy in horses 
that develop POI, it remains possible that anastomotic leaks are underdiagnosed in this species. 
Management of POI 
In human medicine, Enhanced Recovery After Surgery (ERAS) programmes, which include multiple 
pre-, intra- and postoperative interventions, aim to reduce the surgical stress response and rapidly 
return the GI tract to normal physiological function [119].  
In veterinary medicine, no universally-accepted approach to the management of equine POI 
currently exists; however, Figure 2 represents an adaptation of the human ERAS system, which may 
be applicable to horses undergoing abdominal surgery. Veterinary clinicians, who are largely 
informed by knowledge of the relevant veterinary literature, use various pre-, intra- and 
postoperative supportive and therapeutic approaches [8; 9]. These preventive and management 
measures consist mainly of anti-inflammatories, prokinetic and antimicrobial (with prokinetic action) 
medications, along with intravenous fluid therapy (IVFT). Any horse undergoing abdominal surgery is 
‘at risk’ of POI, especially those with SI lesions and a compromised cardiovascular status. Early 
identification of high risk cases permits the prompt adoption of early management strategies.  
Intravenous fluid therapy and electrolytes  
Rehydration and the maintenance of normovolaemia will sustain physiological intravascular volume 
and minimise the development of bowel oedema due to over-hydration. As the risk of bowel 
oedema consequent to over-hydration is greater with intravenous crystalloid fluids, the additional or 
alternative use of colloids may be preferable in some cases [109]. The current recommendation in 
human medicine is to avoid fluid excess by using a near-zero fluid balance approach or using 
restricted IVFT regimens [105; 120; 121]. The intravenous administration of hydroxyethyl starch 
(HES) in conjunction with isotonic saline to horses with colitis or ileus of the SI and LI led to a 
decrease in PCV and heart rate and normalisation of serum urea and creatinine within 24 hours 
[122]; a repeat of this study with larger cohorts is warranted. Hypertonic saline administration to 
rats with interstitial intestinal oedema was found to be beneficial [123]. Postoperatively, ERAS 
schemes recommend oral intake of fluids and discontinuation of IVFT [120; 121]. 
Intestinal manipulation  
Minimisation of tissue handling is likely to have beneficial effects via reduced induction of 
inflammation within the muscularis [28; 29; 37]. However, the potential benefit of limiting the 
degree of intestinal manipulation in equine surgery must be weighed against the increased risk of 
POR associated with inadequate decompression of the SI which may result in kinking, and therefore 
obstruction, of distended SI loops [20]. Studies conducted in rodent models have clearly 
demonstrated an association between the force of manipulation and both the resulting 
inflammatory response and the delay in recovery of GIT motility [29]. Extrapolation of these data 
may suggest that short duration severe handling could have a more detrimental effect on motility 
than longer duration, yet less severe handling. Therefore, despite the inevitable inflammatory 
response induced by the oftentimes multiple manipulations required to fully decompress the SI, it 
would appear prudent to be aware of the potential value of maintaining a gentle technique 
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throughout this procedure. Although multiple enterotomies may theoretically reduce the 
requirement for repeated manipulation of certain intestinal segments, this approach will inevitably 
increase the duration of surgery and would likely increase the risk of postoperative adhesion 
formation and a single enterotomy to decompress the SI is therefore recommended. For 
strangulating obstructions, the bowel to be resected and discarded can be placed over the edge of 
the surgical field to evacuate contents. In strangulating lesions where resection is not deemed 
necessary, performing a single enterotomy to evacuate small intestinal content is less traumatic and 
therefore preferable to manual decompression of the SI, by pushing the contents into the caecum. 
This also has the added benefit of not over-filling the caecum with foul SI luminal contents,  
The use of carboxymethylcellulose (CBMC) should also be considered in at risk cases. Several studies 
in the horse show evidence of the use CBMC reducing adhesion formation, with no adverse effects 
on anastomotic healing [124-128]. If injury, and therefore inflammation can be reduced in the serosa 
of manipulated intestine, then this may also reduce inflammation within the remaining layers of the 
intestine, In the horse, neutrophilic inflammation occurs on the serosal surface of manipulated 
intestine, and within the muscularis, myenteric plexus and submucosal plexus [74]. What is not 
known is if neutrophils migrate from the serosal surface towards the mucosa, or vice versa, following 
manipulation.  
 
Nasogastric intubation 
In humans, the routine use of nasogastric tubes is not associated with an improvement in return to 
normal bowel function [121; 129]; indeed, patients undergoing elective laparotomies had increased 
gastroesophageal reflux when a nasogastric tube was placed [130]. Current recommendations in 
humans is to restrict the use of nasogastric tubes to patients that have delayed gastric emptying 
following surgery [121]. Nasogastric intubation in horses is required to alleviate the clinical signs 
associated with excessive fluid accumulation within the stomach. In contrast to the inclination of 
European equine clinicians to pass a nasogastric tube when required, there is a preference amongst 
North American equine clinicians to retain an indwelling tube [8; 9]; however, there is no evidence 
to suggest that this practice reduces the incidence of POI. Although no evidence based 
recommendations can be offered, the decision to retain an in-dwelling tube is likely informed by a 
variety of case-specific factors, including the rate and amount of reflux, the duration of POI, the 
compliance of the equine patient and the availability of hospital staff. In those cases where an in-
dwelling tube is not retained, the requirement for periodic intubations can be determined by serial 
ultrasonographic examinations to determine the caudal extension of the gastric margin on the left 
side of the horse and the degree of duodenal distension on the right. 
Early feeding and mobilisation 
Early feeding following surgery is a commonly applied prophylactic approach in human medicine. It 
is hypothesised to promote restoration of GI motility via the release of neuropeptides in response to 
solid feed ingestion. Some studies have demonstrated a beneficial effect of chewing gum as a form 
of sham feeding [131]. Early postoperative feeding has been shown to be effective in equine surgical 
cases [30]. The careful introduction of small amounts of good quality roughage at regular intervals as 
soon as possible postoperatively may be indicated in at-risk cases.  For horses with gastric reflux for 
which the provision of enteral nutrition is not possible, the provision of a lick (e.g. mineral block) has 
been suggested as a form of sham feeding, equivalent to gum chewing in humans. In the horse, bit 
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chewing has been suggested as being potentially beneficial to gut motility [132]. Similarly, hanging a 
haynet outside the stable, yet within view, has also been suggested as a potential means of 
providing visual stimulation of GI motility.  
In humans, bed rest increases insulin resistance and muscle loss and decreases muscle strength, 
pulmonary function and tissue oxygenation. Patients are recommended to initiate progressive 
mobilisation after abdominal surgery as early as the first day postoperatively, provided the level of 
analgesia is effective [120]. In horses, the reported benefits of early mobilisation are largely 
anecdotal; however, those that adapt and apply the human ERAS protocol to their equine 
postoperative cases instigate early mobilisation as one of the components of this approach [20].  
Therapeutics 
The two principle pharmacological components of POI treatment include the use of prokinetic and 
anti-inflammatory drugs (Supplementary Item 2). As the neurogenic phase of intestinal amotility is 
considered to resolve upon cessation of the surgical stimuli, targeting the subsequent inflammatory 
phase is a more appropriate approach in the management and treatment of POI.  
Anti-inflammatories 
Non-steroidal anti-inflammatory drugs (NSAIDs) 
In human medicine, the main perceived benefits of NSAID administration include a reduced 
requirement for opioid administration, the commencement of early ambulation and a reduction in 
the COX-2-mediated inflammatory response [133]. The relative merits of each remain unclear. 
Questionnaire-based surveys of North American and European equine veterinary specialists revealed 
flunixin meglumine to be the preferred NSAID of choice for POI prophylaxis and treatment [8; 9], but 
there is no evidence that flunixin reduced the incidence of POI, when  compared with meloxicam 
[114]. Indeed, no studies have been performed in horses showing NSAIDs reduce the incidence of 
POI; however, studies have been performed showing effects of flunixin meglumine and 
phenylbutazone on GI motility in horses with abdominal pain and inflammation. Those NSAIDs are 
believed to have a beneficial effect on the acute systemic side effects of endotoxins, including the 
deterioration in cardiovascular parameters [134]. There is some concern in the human literature that 
NSAIDs affect anastomotic healing [135]. Similarly, studies using various models of equine intestinal 
mucosal injury have highlighted detrimental effects of non-cox-selective NSAIDs on mucosal healing 
and restoration of mucosal integrity [136]. Anastomotic healing, although not directly represented 
by these models, likely shares certain endogenous prostaglandin-dependent processes and is 
theoretically susceptible to disruption by NSAID administration.  
Other anti-inflammatory targets 
Preliminary studies in mice looking at blocking ICAM-1 and the IL-1R either reduced the 
inflammatory response in the muscularis [58] or prevented the development of POI [80]. Alicaforsen 
(an ICAM-1 specific antisense oligonucleotide that reduces receptor expression) is being used in 
human clinical trials for inflammatory bowel disease, but not in POI. Semanipod and the salt CPSI-
2364 inhibits p38 mitogen-activated protein kinase (an intracellular signalling pathway in 
macrophage activation) have been used in mouse and pig models of POI, and have reduced 
inflammation and severity [68; 137; 138]. Another approach is the prophylactic application of vagal 
nerve stimulation, which inhibited macrophage activation in a mouse model [139]. This was termed 
the cholinergic anti-inflammatory pathway, as Ach is the parasympathetic neurotransmitter 
involved. The anti-inflammatory effect is mediated by the release of ACh interacting with nicotinic 
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ACh α-7 receptors (nAChα7R) on macrophages, which is required for the inhibition of cytokine 
synthesis and release [140]. In murine POI models, vagal nerve stimulation reduced the activation of 
MM with a subsequent reduction in infiltrating inflammatory cells and improved GIT [141; 142]. A 
preclinical model using pigs, has demonstrated that laparoscopic abdominal vagal nerve stimulation 
is safe and a potentially viable method [143] as well as a pilot study in humans [144] shows promise 
for its translation into human and even potentially equine medicine. 
Prokinetics 
The most commonly used prokinetics in equine POI management are lidocaine (lignocaine), 
metoclopramide, erythromycin lactobionate and neostigmine [8; 9; 145] and their use and efficacy 
have been much debated in the human and equine clinical literature. The reader is directed to 
review of Wong et al. (2011) for a comprehensive overview of the clinical indications for the use of 
various prokinetic drug classes in the horse, including their modes of action and suggested dosing 
regimens  [146]. Whilst there are several studies supporting the use of lidocaine in the management 
of equine POI [35; 118] a recent review failed to identify any beneficial effects of its use [147]. Traut 
et al. (2008) reviewed the evidence for the clinical efficacy of various prokinetics in man and 
concluded that there was no evidence of efficacy of erythromycin, cholecystokinin, cisapride, 
dopamine-antagonists, propranolol or vasopressin and inconclusive evidence for lidocaine and 
neostigmine [148]. In addition to the lack of evidence regarding their efficacy in POI, the use of any 
antimicrobial product (such as erythromycin) for purposes other than their antimicrobial effects 
remain controversial. 
Evidence of the prokinetic properties of lidocaine is contradictory; some studies demonstrate an 
increase in contractile activity [149; 150], others fail to report any change [151] and one study 
reported an increase in faecal transit time following a continuous lidocaine infusion [152]. Whilst 
lidocaine has always been labelled as a prokinetic drug in the context of POI treatment, any affect 
may be mediated via its analgesic and/or anti-inflammatory properties [153-155], Lidocaine, and 
other local anaesthetics, inhibit several functions of neutrophils, such as adhesion and phagocytosis 
[154]. In an equine jejunal ischaemia model, co-treatment of lidocaine with flunixin resulted in 
reduced mucosal inflammation, characterised by reduced neutrophilic migration, mucosal COX-2 
expression and serum prostaglandin levels [155]. Conversely, the same group, using an in vitro 
model, reported an increase in neutrophilic migration in response to lidocaine [156]. In horses, 
lidocaine did not reduce neutrophil migration into the abdominal cavity following intraperitoneal LPS 
injection, despite a reduction in TNF-α concentration  [157]. These equine-derived data somewhat 
contradict reports in the human literature documenting lidocaine-induced suppression of 
neutrophilic function [158]. Consequently, inter-species variation may exist with respect to the 
effect of lidocaine on neutrophil function. Furthermore, the in vitro effects of lidocaine on neutrophil 
function may differ from the in vivo effects.   
Conclusion 
Most of the proposed mechanisms underlying equine POI are based on rodent and human derived 
data. There is a clear need for the development and application of a standard POI definition in the 
horse to facilitate inter-study comparisons. Such an exercise should lead to the generation of less 
conflicting data on incidence and risk factors and increase the robustness of studies designed to 
evaluate the efficacy of prophylactic and/or therapeutic interventions. 
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Although lidocaine remains one of the most popular drugs of choice for the treatment of equine POI, 
the evidence supporting its clinical efficacy is inconclusive and systematic evaluation of alternative 
pharmacological and physiological approaches in the horse, including alvimopan and vagal nerve 
stimulation is warranted. Whilst the discovery of new and effective therapeutics is important, it 
remains likely that a multimodal approach to POI in the horse, such as an Enhanced Recovery After 
Surgery for Equines (ERASE) scheme (Figure 2) addressing pre-, intra- and postoperative factors, is 
likely to be met with greater success, as it has in human medicine. Such an approach would include 
consideration of surgical factors such as the minimisation of tissue handling, good surgical technique 
and duration of surgery as well as therapeutic interventions. 
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Figure legends: 
Fig 1: Proposed role of the intra-operative factors, surgical incision, intestinal manipulation and 
anastomosis, in the neurogenic and inflammatory phases of POI. 
Fig 2: Suggested Enhanced Recovery after Surgery for Equines (ERASE) protocol. Adapted from 
Lassen et al. 2009. 
 
Supplementary Information 
Supplementary Item 1: Summary of definitions, incidence and identified risk factors of POI in equine 
studies. HR = heart rate; NG = nasogastric; PCV = packed cell volume; POI = postoperative ileus; SI = 
small intestine; TP = total protein. 
Supplementary Item 2: Summary of pharmacological treatments used in the management and 
treatment of POI across the species. Ach = acetylcholine; COX-2 = cycloogygenase-2; D2 = dopamine 
receptor 2; HT = hydroxytryptamine receptor; IL = interleukin; nAChα7R = nicotinic acetylcholine α-7 
receptors; NSAID = non-steroidal anti-inflammatory; POI = postoperative ileus. 
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List of abbreviations 
Ach   acetylcholine 
ATP   adenosine triphosphate 
CNS   central nervous system 
COX-2   cycloogygenase-2  
CSF1R   colony stimulating factor-1 receptor  
CT   computed tomography 
DAMPs  damage-associated molecular patterns 
D2  dopamine receptor 2 
ERAS   Enhanced Recovery After Surgery 
GI  gastrointestinal 
GIT  gastrointestinal tract 
HES   hydroxyethyl starch  
HR  heart rate 
HT  hydroxytryptamine receptor 
ICAM-1  intercellular adhesion molecule 1 
IL   interleukin 
IL-1R   interleukin-1 receptors 
IM  intestinal manipulation 
iNOS   inducible NO synthase  
IVFT   intravenous fluid therapy  
LI  large intestine 
LPS  lipopolysaccharide 
MCP-1   monocyte chemoattractant protein-1  
MIP-1α  macrophage inflammatory protein -1α  
MM   muscularis macrophages 
nAChα7R nicotinic acetylcholine α-7 receptors  
NFκβ   nuclear factor-κβ  
NG  nasogastric 
NO  nitric oxide 
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NSAIDs  non-steroidal anti-inflammatory drugs 
PAMPs  pathogen-associated molecular patterns 
PCV  packed cell volume 
POI  postoperative ileus 
POR  postoperative reflux 
RAGE   receptors for advanced glycation end products 
SI  small intestine 
SM   smooth muscle 
STAT-3   signal transducer and activator of transcription 3 
TLR  toll-like receptor  
TP  total protein 
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